James Openshaw

Plethora Solutions Holdings Plc operates as a pharmaceutical company. It engages in the development and marketing of products for the treatment and management of urological disorders. The firm operates through the Plethora Development and The Urology Co. segments. The Plethora Development segment develops new pharmaceutical products. The Urology Co. segment sells and markets pharmaceutical and healthcare products. The company was founded by Michael Grant Wyllie and Neil Brent Stafford in December 2003 and is headquartered in Chalgrove, the United Kingdom.

Simbec Research Ltd. provides clinical research service to pharmaceutical and biotechnology industries. It conducts drug trails for allergy, anti-infectives, cardiovascular, gastrointestinal, anti-inflammatory, oncology and respiratory. The firm also offers consultancy services, preparation of marketing authorization applications, and clinical trial applications. The company was founded in 1976 and is headquartered in Merthyr Tydfil, the United Kingdom.

BioSeek Plc provides human tissue-based research services for the pharmaceutical industry. It focuses on applying human primary cell assays and predictive disease models to the discovery and development of human therapeutics and safer chemicals. The company was founded by Eugene Butcher in March 1996 and is headquartered in London, the United Kingdom.

Steritrox is the leading innovator of a patented process that delivers rapid whole-room sanitizing and decontamination. The company's technology safely harnesses the science of advanced oxidation to release a cascade of hydroxyl free radicals that simultaneously disinfect both surface and airborne pathogens effectively killing a broad spectrum of bacteria, viruses, moulds and yeasts. This ecologically sensitive programme has been developed for use in enclosed room applications where the powerful sanitizing process culminates in a unique quenching phase that allows rapid room re-entry to satisfy the needs of demanding modern facilities management. Although the technology has a wide application potential the company is currently targeting the food processing industry through its Radical brand and the healthcare sector through its Meditrox brand.

ORION Clinical Services is a full-service clinical development organization. They have in-depth experience of the most challenging therapeutic areas including oncology, intensive care, organ transplant, cystic fibrosis and many more. They offer global reach linked to a level of quality, flexibility and customer service that you would associate with the best local specialist CROs. With headquarters in the UK and offices in France, Germany, USA, Italy and Australia, along with supporting networks of regionally based CRAs in Western, Central and Eastern Europe, North America and Asia, they can offer a truly seamless approach to global drug development.

Simbec-Orion Group Ltd. provides contract research services for rare and orphan conditions. The firm offers services for oncology, orphan diseases, respiratory, dermatology, infectious vaccines and diseases. The company was founded in 2014 and is headquartered in Pentrebach, the United Kingdom.